MeVis cuts FY 2025/26 revenue forecast to EUR 15.0 million-15.5 million

EBIT is now forecast at a loss of EUR 1.0 million to EUR 1.5 million, versus a prior profit of EUR 0.5 million to EUR 1.0 million. The company cited weaker mammography demand at Hologic and slower rollout of lung cancer screening in Germany.